Associations of Leisure-Time Physical Activity and Television Viewing with Life Expectancy Cancer-Free at Age 50: The ARIC Study
Overview
Oncology
Public Health
Authors
Affiliations
Background: Physical activity has been associated with longer chronic disease-free life expectancy, but specific cancer types have not been investigated. We examined whether leisure-time moderate-to-vigorous physical activity (LTPA) and television (TV) viewing were associated with life expectancy cancer-free.
Methods: We included 14,508 participants without a cancer history from the Atherosclerosis Risk in Communities (ARIC) study. We used multistate survival models to separately examine associations of LTPA (no LTPA, <median, ≥median) and TV viewing (seldom/never, sometimes, often/very often) with life expectancy cancer-free at age 50 from invasive colorectal, lung, prostate, and postmenopausal breast cancer. Models were adjusted for age, gender, race, ARIC center, education, smoking, and alcohol intake.
Results: Compared with no LTPA, participants who engaged in LTPA ≥median had a greater life expectancy cancer-free from colorectal [men-2.2 years (95% confidence interval (CI), 1.7-2.7), women-2.3 years (95% CI, 1.7-2.8)], lung [men-2.1 years (95% CI, 1.5-2.6), women-2.1 years (95% CI, 1.6-2.7)], prostate [1.5 years (95% CI, 0.8-2.2)], and postmenopausal breast cancer [2.4 years (95% CI, 1.4-3.3)]. Compared with watching TV often/very often, participants who seldom/never watched TV had a greater colorectal, lung, and postmenopausal breast cancer-free life expectancy of ∼1 year.
Conclusions: Participating in LTPA was associated with longer life expectancy cancer-free from colorectal, lung, prostate, and postmenopausal breast cancer. Viewing less TV was associated with more years lived cancer-free from colorectal, lung, and postmenopausal breast cancer.
Impact: Increasing physical activity and reducing TV viewing may extend the number of years lived cancer-free.
Li P, Yang W, Wang J, Zhu H, Dove A, Xu W J Prev Alzheimers Dis. 2024; 11(6):1712-1720.
PMID: 39559882 PMC: 11573853. DOI: 10.14283/jpad.2024.160.
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.
Bergengren O, Pekala K, Matsoukas K, Fainberg J, Mungovan S, Bratt O Eur Urol. 2023; 84(2):191-206.
PMID: 37202314 PMC: 10851915. DOI: 10.1016/j.eururo.2023.04.021.
Bethea T, Dash C, Adams-Campbell L Cancer Epidemiol. 2022; 78:102146.
PMID: 35325667 PMC: 9133140. DOI: 10.1016/j.canep.2022.102146.
Gao Y, Mi J, Liu Z, Song Q Front Genet. 2021; 12:763626.
PMID: 34777480 PMC: 8582637. DOI: 10.3389/fgene.2021.763626.